Welcome Speech

Prof. James CS Chim, University of Hong Kong, Hong Kong

Clinical use of Immunoglobulin Heavy/light chains in diagnosis and monitoring of multiple myeloma

Dr. Eric Chan, Queen Mary Hospital, Hong Kong

Added Value of 11C-acetate PET/CT to 18F-FDG for the diagnosis and Management of Multiple Myeloma

Dr. Garrett Ho, Hong Kong Sanatorium & Hospital, Hong Kong

Bench to Bedside Translation of Targeted Therapeutics in Multiple Myeloma

Dr. Kenneth C. Anderson, Dana Faber Cancer Institute, USA

Team Break

Transplantation in Myeloma

Prof. Huang Xiaojun, Peking University Institute of Hematology, China

Myeloma in Thailand, the Thai Myeloma Working Group

Dr. Weerasak Nawarawong, Chiang Mai University, Thailand

Frontline treatment for MM in Taiwan – Targeting on novel agents

Dr. Jeffrey Huang, National Taiwan University, Taiwan

Early results of Korean observation study of VMP or lenalidomide for relapsed or refractory MM in Korea

Dr. Kihyun Kim, Samsung Medical Center, Korea

European Perspectives on Frontline Multiple Myeloma Treatment

Prof. Mario Boccadoro, Universita degli Studi di Torino, Italy

Combined Q&A for Session II

Closing Remark

Prof. James CS Chim, University of Hong Kong, Hong Kong

Dinner